[Neoadjuvant chemotherapy in triple-negative breast cancer: is there a role for platinum?]
- PMID: 25776517
- DOI: 10.1684/bdc.2014.2051
[Neoadjuvant chemotherapy in triple-negative breast cancer: is there a role for platinum?]
Comment on
-
Impact of the addition of carboplatin and/or bevacizumab to neoadjuvant once-per-week paclitaxel followed by dose-dense doxorubicin and cyclophosphamide on pathologic complete response rates in stage II to III triple-negative breast cancer: CALGB 40603 (Alliance).J Clin Oncol. 2015 Jan 1;33(1):13-21. doi: 10.1200/JCO.2014.57.0572. Epub 2014 Aug 4. J Clin Oncol. 2015. PMID: 25092775 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
